Sudeep Pharma Ltd.

•

sudeepgroup.comBSE: 544619NSE: SUDEEPPHRM

Market Cap₹ 14,412 Cr.

Current Price

High / Low₹ 1,378 / 524

Stock P/E124.0

Book Value₹ 73

Price to Book8.51

Dividend Yield0.12 %

ROCE20.8 %

ROE17.7 %

Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Chemicals

Hold

The available domestic chemical proxies are mixed to weak. Fertilizers output was -8.0% YoY (2026-07) and sale quantity of fertilisers was 0.0% YoY (2026-05), although that high-frequency barometer is stale. FPI positioning is less negative than before, with net 3-month outflow only INR -11 crore versus INR -1229 crore in the prior 3 months to 2026-08-31, but the weak sector driver argues for a neutral stance.

Confidence

55%

View full sector analysis →

PROS

Company has delivered good profit growth of 25.2% CAGR over last 5 years
Company has a healthy return on capital (ROCE) of 29.5%
Company has a good return on equity (ROE) track record: 3 Years ROE 25.7%
Latest quarter profit grew 34.2% YoY, showing strong momentum
Operating margins have improved to 34.3% from 24.6%

CONS

Promoter holding has decreased over last 2 years: -23.8pp
A large part of profit comes from other income (26.5% of PBT)
Equity base is being diluted - shares outstanding up 701.6%
Working capital days have increased from 176 to 326 days
Stock is trading at 8.5x its book value

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

ChemicalsHealthcarePharmaceuticals & Drugs

Part ofNIFTY MICROCAP250 NIFTY TOTAL MKT

S.No.	Name
1.	SUNPHARMA	1868.50	37.06	448315.74	0.86	2901.23	26.53	15299.88	10.98	19.11	28.81
2.	DIVISLAB	9482.75	86.06	251737.22	0.32	902.00	65.50	3080.00	27.80	21.51	40.75
3.	TORNTPHARM	4931.90	86.01	187593.62	0.77	566.00	3.28	4921.00	57.32	19.27	33.81
4.	ZYDUSLIFE	1129.00	24.95	112618.18	0.09	990.20	-34.90	8017.00	23.97	21.39	24.54
5.	CIPLA	1368.00	32.79	110515.04	0.95	785.55	-39.18	7119.28	4.13	16.00	16.73
6.	LAURUSLABS	1933.25	95.54	104455.86	0.10	362.07	123.94	2026.31	29.10	18.20	31.50
7.	AUROPHARMA	1690.00	26.19	97238.86	0.24	1032.03	25.22	9150.35	17.44	12.76	20.54
8.	LUPIN	2092.00	17.30	95660.02	0.86	1416.98	16.01	8276.89	34.28	28.86	29.59
9.	DRREDDY	1143.20	29.61	95420.61	0.70	435.60	-69.10	8099.80	-5.21	13.75	10.63
10.	MANKIND	2266.00	45.82	93596.02	0.04	574.09	29.12	4030.59	12.89	13.24	26.30
11.	GLENMARK	2439.55	38.29	68850.12	0.10	482.83	927.88	4018.48	31.35	20.35	20.03
12.	SUDEEPPHRM	1276.00	78.91	14412.24	0.12	405.87	1197.99	1582.70	1166.99	28.50	34.70

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	106	83	105	80	88	90	80	106
	66	57	59	53	57	61	51	70
Operating Profit	40	26	45	27	31	30	29	36
OPM %	37.82%	31.70%	43.36%	33.93%	35.14%	32.80%	36.04%	33.69%
	1	2	3	7	13	9	10	10
Interest	1	1	2	1	2	1	2	2
Depreciation	1	2	2	2	2	2	2	2
Profit before Tax	39	26	45	34	40	37	35	45
Tax %	25.36%	20.56%	26.83%	25.49%	25.46%	26.65%	25.85%	25.50%
Net Profit	29	21	33	25	30	27	26	34
	2.71	1.90	3.05	2.29	2.67	2.42	2.31	3.00

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	50	59	89	123	218	345	404	344	357	339	364
	38	46	72	98	172	277	316	211	224	218	239
Operating Profit	12	13	18	25	46	68	88	133	133	120	125
OPM %	23.77%	21.48%	19.71%	20.64%	21.01%	19.76%	21.85%	38.67%	37.24%	35.58%	34.34%
	1	2	3	3	4	8	11	8	8	39	42
Interest	0	0	1	1	1	2	4	4	6	7	6
Depreciation	1	2	2	3	4	4	5	5	6	7	7
Profit before Tax	12	13	18	25	45	70	91	132	129	145	157
Tax %	36.62%	27.01%	33.70%	26.68%	22.17%	25.70%	26.00%	25.87%	26.01%	25.86%	25.84%
Net Profit	7	9	12	18	35	52	67	98	96	108	116
EPS	52.83	66.92	83.39	128.02	248.29	371.20	476.69	696.04	9.85	9.52	—
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	15.75%	—

COMPOUNDED SALES GROWTH

10 Years:: 23%
5 Years:: 9%
3 Years:: -6%

COMPOUNDED PROFIT GROWTH

10 Years:: 37%
5 Years:: 25%
3 Years:: 17%

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: —

RETURN ON EQUITY

10 Years:: 27%
5 Years:: 29%
3 Years:: 26%
Last Year:: 18%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	1	1	1	1	1	1	1	1	10	11
	40	50	61	80	115	167	235	333	418	775
	4	4	8	20	31	73	70	53	113	117
Trade Payables	4	6	6	9	17	24	39	34	36	43
	4	4	16	21	50	68	70	29	28	28
Total Liabilities	54	66	93	131	214	333	416	451	604	974
	26	32	54	60	68	120	81	96	105	102
Capital Work in Progress	1	9	1	8	23	4	26	43	88	158
	4	1	0	6	24	15	19	29	32	32
	9	4	8	9	15	26	52	45	65	131
	0	0	0	0	0	0	0	141	162	80
Cash & Bank	1	3	4	4	8	15	6	9	45	90
	13	17	26	44	75	153	232	87	107	381
Total Assets	54	66	93	131	214	333	416	451	604	974

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	7	17	17	16	46	12	64	59	59	96
Cash from Investing	-6	-12	-15	-22	-45	-28	-41	-41	-92	-367
Cash from Financing	2	-0	3	12	13	40	-10	-16	54	243
	0	1	2	-0	4	7	-9	2	22	-28

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Nov 2025	Dec 2025	Mar 2026	Jun 2026
	100.00	100.00	100.00	100.00	44.65	76.15	76.15	76.15	76.15
	0.00	0.00	0.00	0.00	0.00	1.54	1.67	1.55	1.81
	0.00	0.00	0.00	0.00	0.00	14.10	17.59	18.11	15.65
Government	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	0.00	0.00	0.00	0.00	55.35	8.20	4.58	4.18	6.39

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-11

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-11 - Sudeep Pharma Limited has informed the Exchange about Transcript

2026-08-06

Updates

2026-08-06 - Sudeep Pharma Limited has informed the Exchange regarding 'General Update'.

2026-08-05

Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-05 - Sudeep Pharma Limited has informed the Exchange about Link of Recording

2026-08-05

Shareholders meeting

2026-08-05 - Sudeep Pharma Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 04, 2026. Further, the company has informed the Exchange regarding voting results.

2026-08-05

Copy of Newspaper Publication

2026-08-05 - Sudeep Pharma Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-04

Investor Presentation

2026-08-04 - Sudeep Pharma Limited has informed the Exchange about Investor Presentation

2026-08-04

Investor Presentation

2026-08-04 - Sudeep Pharma Limited has informed the Exchange about Investor Presentation

2026-08-04

Outcome of Board Meeting

2026-08-04 - Sudeep Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-08-04

Shareholders meeting

2026-08-04 - Sudeep Pharma Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 04, 2026

News

Recent coverage and analyst commentary for SUDEEPPHRM

Loading news…

🤖

AI Stock Analyst

Sudeep Pharma Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

SUNPHARMA

1868.50

37.06

448315.74

0.86

2901.23

26.53

15299.88

10.98

19.11

28.81

DIVISLAB

9482.75

86.06

251737.22

0.32

902.00

65.50

3080.00

27.80

21.51

40.75

TORNTPHARM

4931.90

86.01

187593.62

0.77

566.00

3.28

4921.00

57.32

19.27

33.81

ZYDUSLIFE

1129.00

24.95

112618.18

0.09

990.20

-34.90

8017.00

23.97

21.39

24.54

CIPLA

1368.00

32.79

110515.04

0.95

785.55

-39.18

7119.28

4.13

16.00

16.73

LAURUSLABS

1933.25

95.54

104455.86

0.10

362.07

123.94

2026.31

29.10

18.20

31.50

AUROPHARMA

1690.00

26.19

97238.86

0.24

1032.03

25.22

9150.35

17.44

12.76

20.54

LUPIN

2092.00

17.30

95660.02

0.86

1416.98

16.01

8276.89

34.28

28.86

29.59

DRREDDY

1143.20

29.61

95420.61

0.70

435.60

-69.10

8099.80

-5.21

13.75

10.63

MANKIND

2266.00

45.82

93596.02

0.04

574.09

29.12

4030.59

12.89

13.24

26.30

GLENMARK

2439.55

38.29

68850.12

0.10

482.83

927.88

4018.48

31.35

20.35

20.03

SUDEEPPHRM

1276.00

78.91

14412.24

0.12

405.87

1197.99

1582.70

1166.99

28.50

34.70

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Jun 2026

106

105

106

Operating Profit

OPM %

37.82%

31.70%

43.36%

33.93%

35.14%

32.80%

36.04%

33.69%

Interest

Depreciation

Profit before Tax

Tax %

25.36%

20.56%

26.83%

25.49%

25.46%

26.65%

25.85%

25.50%

Net Profit

2.71

1.90

3.05

2.29

2.67

2.42

2.31

3.00

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

TTM

123

218

345

404

344

357

339

364

172

277

316

211

224

218

239

Operating Profit

133

120

125

OPM %

23.77%

21.48%

19.71%

20.64%

21.01%

19.76%

21.85%

38.67%

37.24%

35.58%

34.34%

Interest

Depreciation

Profit before Tax

132

129

145

157

Tax %

36.62%

27.01%

33.70%

26.68%

22.17%

25.70%

26.00%

25.87%

26.01%

25.86%

25.84%

Net Profit

108

116

EPS

52.83

66.92

83.39

128.02

248.29

371.20

476.69

696.04

9.85

9.52

—

Dividend Payout %

0.00%

15.75%

—

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

115

167

235

333

418

775

113

117

Trade Payables

Total Liabilities

131

214

333

416

451

604

974

120

105

102

Capital Work in Progress

158

131

141

162

Cash & Bank

153

232

107

381

Total Assets

131

214

333

416

451

604

974

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Cash from Investing

-6

-12

-15

-22

-45

-28

-41

-92

-367

Cash from Financing

-0

-10

-16

243

-0

-9

-28

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Nov 2025

Dec 2025

Mar 2026

Jun 2026

100.00

44.65

76.15

0.00

1.54

1.67

1.55

1.81

0.00

14.10

17.59

18.11

15.65

Government

0.00

55.35

8.20

4.58

4.18

6.39

Sudeep Pharma Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Sudeep Pharma Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI